CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
CloneSig is reported to have the capability to jointly infer intra-tumor heterogeneity and mutational signature activity. This inference is said to be possible in bulk tumor sequencing data. The tool's functionality appears to be focused on analyzing tumor data.